DE69001107D1 - Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen. - Google Patents
Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen.Info
- Publication number
- DE69001107D1 DE69001107D1 DE9090870135T DE69001107T DE69001107D1 DE 69001107 D1 DE69001107 D1 DE 69001107D1 DE 9090870135 T DE9090870135 T DE 9090870135T DE 69001107 T DE69001107 T DE 69001107T DE 69001107 D1 DE69001107 D1 DE 69001107D1
- Authority
- DE
- Germany
- Prior art keywords
- fatty acid
- oxygen
- retroviral infections
- acid analogs
- substituted fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/60—Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/402,094 US5073571A (en) | 1988-06-16 | 1989-09-01 | Method of inhibiting virus |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69001107D1 true DE69001107D1 (de) | 1993-04-22 |
DE69001107T2 DE69001107T2 (de) | 1993-10-07 |
Family
ID=23590495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE90870135T Expired - Fee Related DE69001107T2 (de) | 1989-09-01 | 1990-08-31 | Sauerstoff- oder schwefelsubstituierte Fettsäureanaloga zur Behandlung retroviraler Infektionen. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5073571A (de) |
EP (1) | EP0415902B1 (de) |
JP (1) | JPH0714875B2 (de) |
AT (1) | ATE86854T1 (de) |
CA (1) | CA2024489A1 (de) |
DE (1) | DE69001107T2 (de) |
DK (1) | DK0415902T3 (de) |
ES (1) | ES2055407T3 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE141644T1 (de) * | 1990-02-26 | 1996-09-15 | Univ Washington | Verfahren zur protein-n-myristoylation |
US5236955A (en) * | 1992-04-10 | 1993-08-17 | Washington University | Anti-fungal agent |
US6602861B1 (en) * | 1992-04-16 | 2003-08-05 | Research Corporation Technologies, Inc. | Acylated phospholipid drugs |
US5463152A (en) * | 1994-12-08 | 1995-10-31 | E. I. Du Pont De Nemours And Company | Halofluorocarbon hydrogenolysis |
GB2267642B (en) * | 1992-06-10 | 1996-04-24 | British Tech Group | Anti-viral agents |
GB9212276D0 (en) * | 1992-06-10 | 1992-07-22 | Harper David R | Anti-viral agents |
US5859052A (en) * | 1993-01-14 | 1999-01-12 | G. D. Searle & Co. | Fatty acid analogs and prodrugs |
US5599947A (en) * | 1993-01-14 | 1997-02-04 | G. D. Searle & Co. | Fatty acid analogs and prodrugs |
DE10063111A1 (de) * | 2000-12-18 | 2002-06-20 | Bayer Ag | Replikationsassay zur Auffindung antiviraler Substanzen |
US9144575B2 (en) | 2010-07-28 | 2015-09-29 | Life Technologies Corporation | Anti-viral azide containing compounds |
US20120028335A1 (en) | 2010-07-28 | 2012-02-02 | Life Technologies Corporation | Anti-viral azide-containing compounds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2262514A1 (en) * | 1974-03-01 | 1975-09-26 | Alary Josette | Reticulo-endothelial stimulating compsn. - contg. sodium oleate, sodium stearate and neutralised olive oil |
US4513005A (en) * | 1981-06-18 | 1985-04-23 | Lilly Industries Limited | SRS-A antagonists |
US4740588A (en) * | 1986-08-07 | 1988-04-26 | Washington University | Novel substrate peptides |
US4709012A (en) * | 1986-08-07 | 1987-11-24 | Washington University | Novel inhibitor peptides |
-
1989
- 1989-09-01 US US07/402,094 patent/US5073571A/en not_active Expired - Fee Related
-
1990
- 1990-08-31 JP JP2232269A patent/JPH0714875B2/ja not_active Expired - Lifetime
- 1990-08-31 AT AT90870135T patent/ATE86854T1/de not_active IP Right Cessation
- 1990-08-31 ES ES90870135T patent/ES2055407T3/es not_active Expired - Lifetime
- 1990-08-31 EP EP90870135A patent/EP0415902B1/de not_active Expired - Lifetime
- 1990-08-31 CA CA002024489A patent/CA2024489A1/en not_active Abandoned
- 1990-08-31 DK DK90870135.2T patent/DK0415902T3/da active
- 1990-08-31 DE DE90870135T patent/DE69001107T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH03109322A (ja) | 1991-05-09 |
DK0415902T3 (da) | 1993-04-19 |
EP0415902A1 (de) | 1991-03-06 |
ES2055407T3 (es) | 1994-08-16 |
EP0415902B1 (de) | 1993-03-17 |
DE69001107T2 (de) | 1993-10-07 |
ATE86854T1 (de) | 1993-04-15 |
CA2024489A1 (en) | 1991-03-02 |
JPH0714875B2 (ja) | 1995-02-22 |
US5073571A (en) | 1991-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE102617T1 (de) | Verfahren zur herstellung von zyklischen estern hoher reinheit. | |
AU2867089A (en) | (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active ingredient | |
DE3868886D1 (de) | Fettsaeure-zusammensetzungen. | |
DE69019111D1 (de) | Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion. | |
DE3887247D1 (de) | Feste unverdauliche fettähnliche Verbindungen. | |
ATE105482T1 (de) | Behandlung von krebs mit somatostatin und mit analogen davon. | |
DE69001107D1 (de) | Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen. | |
DE3685797D1 (de) | Clausverfahren zur herstellung von schwefel in gegenwart erhoehter sauerstoffmengen. | |
DE69212925D1 (de) | Polymerisationsinhibitoren für Acrylsäure und Ester | |
DE3878313D1 (de) | Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. | |
DE68916754D1 (de) | Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure. | |
AU631738B2 (en) | Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis | |
DE59003144D1 (de) | Destillationsanlage zur Herstellung von Wasserstoff-Peroxid. | |
DE69427955D1 (de) | Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern | |
DK0441765T3 (da) | Nye enzymsubstrater på basis af fedtsyreanaloger | |
ATE95836T1 (de) | Zum abbau von glycosaminoglycan faehige enzymzusammensetzung und verfahren zur herstellung dieser zusammensetzung. | |
ATE120730T1 (de) | 3.3'-dithiobis (propionsäuren) und estern davon. | |
ES2062282T3 (es) | Proceso de racemizacion de esteres del acido carboxilico opticamente activos. | |
ATE114468T1 (de) | Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs. | |
ATE85893T1 (de) | Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis. | |
ATE93832T1 (de) | Verfahren zur herstellung von 4,6-dimethyl-7hydroxynonan-3-on. | |
DE59100505D1 (de) | Verfahren zur Herstellung von Estern. | |
DE68928788D1 (de) | Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten | |
DE68924499D1 (de) | Verfahren zur Herstellung von Phosphatidylcholin Derivaten. | |
IT1247508B (it) | Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |